These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 39227882)
1. ALS-associated C21ORF2 variant disrupts DNA damage repair, mitochondrial metabolism, neuronal excitability and NEK1 levels in human motor neurons. Zelina P; de Ruiter AA; Kolsteeg C; van Ginneken I; Vos HR; Supiot LF; Burgering BMT; Meye FJ; Veldink JH; van den Berg LH; Pasterkamp RJ Acta Neuropathol Commun; 2024 Sep; 12(1):144. PubMed ID: 39227882 [TBL] [Abstract][Full Text] [Related]
2. C21orf2 variants causing inherited retinal disease: A review of what we know and a report of two new suspected cases. Shinbashi M; Jewell A; Randolph J; Couser N Clin Case Rep; 2023 Mar; 11(3):e7110. PubMed ID: 36950666 [TBL] [Abstract][Full Text] [Related]
3. Modeling neuromuscular diseases in zebrafish. Singh J; Patten SA Front Mol Neurosci; 2022; 15():1054573. PubMed ID: 36583079 [TBL] [Abstract][Full Text] [Related]
5. Aging-Dependent Altered Transcriptional Programs Underlie Activity Impairments in Human C9orf72-Mutant Motor Neurons. Sommer D; Rajkumar S; Seidel M; Aly A; Ludolph A; Ho R; Boeckers TM; Catanese A Front Mol Neurosci; 2022; 15():894230. PubMed ID: 35774867 [TBL] [Abstract][Full Text] [Related]
6. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. van Rheenen W; van der Spek RAA; Bakker MK; van Vugt JJFA; Hop PJ; Zwamborn RAJ; de Klein N; Westra HJ; Bakker OB; Deelen P; Shireby G; Hannon E; Moisse M; Baird D; Restuadi R; Dolzhenko E; Dekker AM; Gawor K; Westeneng HJ; Tazelaar GHP; van Eijk KR; Kooyman M; Byrne RP; Doherty M; Heverin M; Al Khleifat A; Iacoangeli A; Shatunov A; Ticozzi N; Cooper-Knock J; Smith BN; Gromicho M; Chandran S; Pal S; Morrison KE; Shaw PJ; Hardy J; Orrell RW; Sendtner M; Meyer T; Başak N; van der Kooi AJ; Ratti A; Fogh I; Gellera C; Lauria G; Corti S; Cereda C; Sproviero D; D'Alfonso S; Sorarù G; Siciliano G; Filosto M; Padovani A; Chiò A; Calvo A; Moglia C; Brunetti M; Canosa A; Grassano M; Beghi E; Pupillo E; Logroscino G; Nefussy B; Osmanovic A; Nordin A; Lerner Y; Zabari M; Gotkine M; Baloh RH; Bell S; Vourc'h P; Corcia P; Couratier P; Millecamps S; Meininger V; Salachas F; Mora Pardina JS; Assialioui A; Rojas-García R; Dion PA; Ross JP; Ludolph AC; Weishaupt JH; Brenner D; Freischmidt A; Bensimon G; Brice A; Durr A; Payan CAM; Saker-Delye S; Wood NW; Topp S; Rademakers R; Tittmann L; Lieb W; Franke A; Ripke S; Braun A; Kraft J; Whiteman DC; Olsen CM; Uitterlinden AG; Hofman A; Rietschel M; Cichon S; Nöthen MM; Amouyel P; ; ; ; ; Traynor BJ; Singleton AB; Mitne Neto M; Cauchi RJ; Ophoff RA; Wiedau-Pazos M; Lomen-Hoerth C; van Deerlin VM; Grosskreutz J; Roediger A; Gaur N; Jörk A; Barthel T; Theele E; Ilse B; Stubendorff B; Witte OW; Steinbach R; Hübner CA; Graff C; Brylev L; Fominykh V; Demeshonok V; Ataulina A; Rogelj B; Koritnik B; Zidar J; Ravnik-Glavač M; Glavač D; Stević Z; Drory V; Povedano M; Blair IP; Kiernan MC; Benyamin B; Henderson RD; Furlong S; Mathers S; McCombe PA; Needham M; Ngo ST; Nicholson GA; Pamphlett R; Rowe DB; Steyn FJ; Williams KL; Mather KA; Sachdev PS; Henders AK; Wallace L; de Carvalho M; Pinto S; Petri S; Weber M; Rouleau GA; Silani V; Curtis CJ; Breen G; Glass JD; Brown RH; Landers JE; Shaw CE; Andersen PM; Groen EJN; van Es MA; Pasterkamp RJ; Fan D; Garton FC; McRae AF; Davey Smith G; Gaunt TR; Eberle MA; Mill J; McLaughlin RL; Hardiman O; Kenna KP; Wray NR; Tsai E; Runz H; Franke L; Al-Chalabi A; Van Damme P; van den Berg LH; Veldink JH Nat Genet; 2021 Dec; 53(12):1636-1648. PubMed ID: 34873335 [TBL] [Abstract][Full Text] [Related]
7. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Perez-Riverol Y; Bai J; Bandla C; García-Seisdedos D; Hewapathirana S; Kamatchinathan S; Kundu DJ; Prakash A; Frericks-Zipper A; Eisenacher M; Walzer M; Wang S; Brazma A; Vizcaíno JA Nucleic Acids Res; 2022 Jan; 50(D1):D543-D552. PubMed ID: 34723319 [TBL] [Abstract][Full Text] [Related]
8. Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation. Huang X; Roet KCD; Zhang L; Brault A; Berg AP; Jefferson AB; Klug-McLeod J; Leach KL; Vincent F; Yang H; Coyle AJ; Jones LH; Frost D; Wiskow O; Chen K; Maeda R; Grantham A; Dornon MK; Klim JR; Siekmann MT; Zhao D; Lee S; Eggan K; Woolf CJ Cell Rep; 2021 Jun; 35(10):109224. PubMed ID: 34107252 [TBL] [Abstract][Full Text] [Related]
14. An Amyotrophic Lateral Sclerosis-Associated Mutant of C21ORF2 Is Stabilized by NEK1-Mediated Hyperphosphorylation and the Inability to Bind FBXO3. Watanabe Y; Nakagawa T; Akiyama T; Nakagawa M; Suzuki N; Warita H; Aoki M; Nakayama K iScience; 2020 Aug; 23(9):101491. PubMed ID: 32891887 [TBL] [Abstract][Full Text] [Related]
15. Amyotrophic lateral sclerosis: a clinical review. Masrori P; Van Damme P Eur J Neurol; 2020 Oct; 27(10):1918-1929. PubMed ID: 32526057 [TBL] [Abstract][Full Text] [Related]
16. The TLK1/Nek1 axis contributes to mitochondrial integrity and apoptosis prevention via phosphorylation of VDAC1. Singh V; Khalil MI; De Benedetti A Cell Cycle; 2020 Feb; 19(3):363-375. PubMed ID: 31914854 [TBL] [Abstract][Full Text] [Related]